|Articles|October 26, 2017
CRF Health’s TrialMax Touch® Solution Selected for Landmark Global Oncology Study
Advertisement
CRF Health announced that its TrialMax Touch® solution has been selected for a landmark global oncology trial. The trial will involve more than 1,000 patients across 200 sites in 20 countries and provide a version of TrialMax solution to all involved. Not only does this solution increase insight to Patient Reported Outcomes, but it also streamlines data collection by capturing the data.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Bringing Clinical Trials Into the Digital Era with eConsent
2
Global Breast Cancer Trials Show Progress in Diversity, But Gaps Remain
3
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
4
Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
